+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 142 Pages
  • June 2022
  • Region: Global
  • IMARC Group
  • ID: 5615027
The global radiodermatitis market reached a value of US$ 464.4 Million in 2021. Looking forward, the publisher expects the market to reach a value of US$ 579.5 Million by 2027, exhibiting a CAGR of 3.76% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient’s life.

Radiodermatitis Market Trends:


The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:


The publisher provides an analysis of the key trends in each sub-segment of the global radiodermatitis market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

  • Topical
  • Corticosteroids
  • Hydrophilic Creams
  • Antibiotics
  • Others
  • Oral
  • Dressings
  • Hydrogel and Hydrocolloid Dressings
  • No Sting Barrier Film
  • Honey Impregnated Gauze
  • Silicone Coated Dressings
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:


The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report:

  • How has the global radiodermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global radiodermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global radiodermatitis market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Radiodermatitis Market

What is the estimated value of the Global Radiodermatitis Market?

The Global Radiodermatitis Market was estimated to be valued at $464.4 Million in 2021.

What is the growth rate of the Global Radiodermatitis Market?

The growth rate of the Global Radiodermatitis Market is 3.7%, with an estimated value of $579.5 Million by 2027.

What is the forecasted size of the Global Radiodermatitis Market?

The Global Radiodermatitis Market is estimated to be worth $579.5 Million by 2027.

Who are the key companies in the Global Radiodermatitis Market?

Key companies in the Global Radiodermatitis Market include 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc and Mölnlycke Health Care AB.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Radiodermatitis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Topical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Corticosteroids
6.1.2.2 Hydrophilic Creams
6.1.2.3 Antibiotics
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Oral
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Dressings
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Hydrogel and Hydrocolloid Dressings
6.3.2.2 No Sting Barrier Film
6.3.2.3 Honey Impregnated Gauze
6.3.2.4 Silicone Coated Dressings
6.3.2.5 Others
6.3.3 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Pharmacy
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 3M Company
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Bausch Health Companies Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Bayer AG
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 BMG PHARMA S.p.A.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Charles River Laboratories International Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 ConvaTec Group plc
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Helsinn Healthcare SA
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 ICON plc
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Integra LifeSciences
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Mölnlycke Health Care AB
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 SWOT Analysis
13.3.11 Stratpharma AG
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
List of Figures
Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2021
Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2021
Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2021
Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Radiodermatitis Market: Competitive Structure
Table 6: Global: Radiodermatitis Market: Key Players

Companies Mentioned

  • 3M Company
  • Bausch Health Companies Inc.
  • Bayer AG
  • BMG PHARMA S.p.A.
  • Charles River Laboratories International Inc.
  • ConvaTec Group plc
  • Helsinn Healthcare SA
  • ICON plc
  • Integra LifeSciences
  • Mölnlycke Health Care AB
  • Stratpharma AG.

Methodology

Loading
LOADING...